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ABSTRACT 
Zeolite particles with different pore diameter and particle size were loaded with the 
model anticancer drug 5-fluorouracil. The loaded zeolites were characterized by 
means of SEM, XRD, DSC, XPS, N2 physisorption and FT-IR.  Higher loading of 5-
FU was observed for NaX-FAU than BEA. Release studies were carried out in 
simulated gastric fluid. Release of 5-FU from NaX-FAU showed exponential-type 
behaviour with the drug fully released within 10 min. In the case of BEA, the kinetics 
of 5-FU shows a multi-step profile with prolonged release over time. Molecular 
dynamics simulations showed that diffusion of the drug molecule through the BEA 
framework is lower than for NaX-FAU due to increased van der Waals interaction 
between the drug and the framework. The effect of zeolitic particles on the viability of 
Caco-2 monolayers showed that the NaX-FAU particles cause a reduction of cell 
viability in a more pronounced way compared with the BEA particles.  
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Background 
Zeolites are microporous materials with regular pore architectures and compositions 
with cages and channels running through them.
1,2
 Their properties, such as ion-
exchange, separation, and catalysis, and their roles as hosts in nanocomposite 
materials, are essentially determined by their unique structural characteristics, such as 
the size of the pore window, the accessible void space, the dimensionality of the 
channel system, and the numbers, sites and types of extra framework cations.
2
 The 
dimensions of these pores, channels and cages are such that drug molecules can be 
accommodated inside them.
3-7
 Moreover, the drug molecules are likely to diffuse out 
of the channel systems slowly, thus controlling their release rate. In a previous study 
we investigated the effect of different loading procedures on the release profile of the 
active compound.
7 
In an attempt to investigate the effect of different types of zeolites 
on the release kinetics and the physical state of the active compound, the anticancer 
drug 5-fluorouracil (5-FU) was encapsulated into NaX-FAU and BEA zeolitic 
particles. These two zeolites differ in framework type, pore diameter, and particle 
size. Specifically, the BEA framework type belongs to the tetragonal crystal system 
having an 3-dimentional channel 12 member ring pore system comprising straight and 
sinusoidal channels along the <100> and [001] with 6.6 x 6.7 Å and 5.6 x 5.6 Å 
openings respectively, however the maximum diameter of a sphere that can diffuse 
along its channels for all three crystallographic directions is 5.95 Å. NaX-FAU 
belongs to the cubic system containing supercages with ~ 13 Å that communicate 
through ~7.35 Å windows. Additionally the effect of Si/Al ratios ~250 for BEA; less 
than 1.5 for NaX-FAU and the hydrophobicity of zeolitic particles (BEA zeolite is 
more hydrophobic compared to NAX-FAU ) to the encapsulation and release of 5-FU 
were further assessed.  
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5-FU is an anticancer agent poorly absorbed with variations in bioavailability ranging 
between 0 and 80%. On the other hand parenteral administration of FU, it is rapidly 
eliminated with an apparent terminal half-life of approximately 8–20 min.8 
In view of the promise of zeolites as carriers via the oral route of administration, we 
have characterized zeolitic particles loaded with 5-FU by means of scanning electron 
microscopy (SEM), N2 physisorption, powder x-ray diffraction (XRD), differential 
scanning calorimetry (DSC), X-ray photoelectron spectroscopy (XPS) and fourier-
transform infrared spectroscopy (FT-IR). Their cytotoxicity was assessed by means of 
(thiazolyl blue tetrazolium bromide) MTT assay to Caco-2 cell lines. The release 
profiles of the loaded particles were evaluated in simulated gastric fluid. Finally these 
studies were complemented by molecular dynamic calculations.  
Methods 
Materials 
 Molecular sieves, 13X powder, ~2 μm average particle size were purchased from 
Sigma-Aldrich. All purchased chemicals were used as received without further 
purification. 5-FU was obtained from Sigma-Aldrich. The synthesis and 
characterisation by means of Scanning Electron Microscopy and N2 physisorption 
studies of BEA zeolitic nanoparticles is described in SI. 
 Preparation of drug loaded zeolites 
200 mg of zeolite was impregnated in 30 mL of an ethanolic containing 80 mg of 5-
FU under constant stirring at room temperature for 24 h.  The solvent was removed by 
filtration through MF-Millipore
TM
 membrane filters, pore size 0.05 μm for BEA and 
0.45 μm for NaX-FAU zeolites respectively and then dried at 40oC for 24 h. The 
loading efficiency of the zeolite particles was determined by adding 10 mg of loaded 
samples in 20 mL EtOH and stirred for 24 h. The samples were centrifuged in a 
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Heraeus Labofuge 400 R at 4000 rpm for 30 min. The supernatant was collected and 
determined with a UV-1700 spectrophotometer Shimadzu at 266 nm. 
Characterization of the zeolite loaded particles 
The zeolite loaded particles were characterized by means of XRD, FTIR, DSC and 
XPS (For details see SI). 
Stability studies of zeolitic particles in dissolution medium 
The effect of the medium on the zeolite NaX-FAU framework was determined as 
reported previously with little modification. Briefly, 50 mg of zeolite particles were 
incubated in 20 mL of HCl 0.1 M pH 1.2 for 5 and 120 min respectively. The samples 
were centrifuged in a Heraeus Labofuge 400 R at 4000 rpm for 30 min. The 
supernatants were collected and dried at 40
o
C for 24 h and further analyzed by means 
of SEM and XRD. 
Molecular modeling – Dissolution studies 
Molecular dynamics (MD) simulations were performed using the program Materials 
Studio version 6.0 and drug release from loaded zeolites samples was studied by using 
a USP/Ph.Eur. paddle dissolution apparatus (Pharma Test PT-DT7). All release 
studies were carried out under sink conditions in triplicate.  (For details see SI). 
Cell viability - MTT assay - Transepithelial electrical resistance (TEER) studies  
Viability of Caco-2 cells was evaluated using the MTT assay based on the ability of 
viable cells to convert thiazolyl blue tetrazolium bromide solution to the blue 
formazan crystals in their mitochondria.
9
 Also, by recording the formulation-induced 
changes in transepithelial electrical resistance (TEER), the use of Caco-2 monolayers 
as an in vitro probe of the potential permeation-enhancing capacity of the applied 
formulation has been employed.
10
 (For details see SI). 
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Results 
Characterization of zeolitic particles 
 The textural properties of the zeolitic particles are illustrated at Table S1 (SI). 
Scanning electron microscopy studies revealed that the NaX-FAU particles exhibited 
multi-faceted spherulite crystals with a mean diameter of 1.98 ± 0.30 μm as 
determined by digital image analysis (Figure 1A, Table S1, SI).
11
 On the contrary the 
BEA particles had a mean diameter of 140 ± 47 nm (Figure 1B, Table S1, SI).  The 
N2 physisorption isotherm in the BEA and NaX-FAU crystals (Figure 1C and 1D) 
corresponds to a type I isotherm according to the IUPAC classification. 
Characterization of the drug loaded particles   
The X-ray diffractograms of all samples are shown in Figure 2A. The loaded samples 
exhibit the characteristic reflections of NaX-FAU and BEA zeolites, respectively, 
indicating that the encapsulation procedure did not destroy the zeolite structure. 
Specifically for the drug-loaded NaX-FAU diffractograms, a change in relative 
intensities of the (220) and (311) diffraction peaks before and after the encapsulation 
can be seen (Figure 1A), while all reflections show a slightly increased intensity. This 
observation might be due to the presence of drug molecules in the zeolite pore 
network or on the surface. Moreover, the presence of a characteristic peak, attributed 
to the (200) Miller plane of 5-FU at 27.5
o
, in the NaX-FAU loaded sample indicates 
the presence of crystalline drug. In the case of BEA, the XRD pattern (Figure 2A) is 
dominated by the peaks associated with BEA, with a notable absence of any peaks 
associated with 5-FU, suggesting an absence of crystalline 5-FU.
7,11
 
The FTIR spectra of pure 5-FU, drug loaded zeolites and empty zeolites are shown in 
Figure 2B. Residual ethanol in the samples was not detected as evident from Figure 
2B. In the case of pure drug the characteristic bands at  1667 and 1247 cm
-1
 are 
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assigned to the overlapped stretching vibration absorption of C=O, C=C and C–N 
respectively. Absorption at 1435 cm
−1
 is due to in-plane bending vibration of C–H in 
(–CF=CH–) and at 813 cm−1 is assigned to out-of-plane bending vibration absorption 
of C-H in (-CF=CH-). The band at 1725 cm
-1
 is assigned to stretching vibrations of 
C=O and N-H in cyclic imide (CO-NH-CO).
12,13
 It is apparent that characteristic 
bands of 5-FU are recognized in the spectrum of NaX-FAU loaded samples 
suggesting that that the drug is associated with the zeolitic NaX-FAU microparticles. 
An additional interesting observation is that in all FTIR spectra, a broad absorption 
band in the range of 3000-3800 cm
-1
 is present in all zeolite samples (both empty and 
loaded), which can be attributed to the presence of strongly bound crystal water, and 
indicates that the loading treatment has not significantly affected the hydration state of 
the zeolites. 
In the DSC thermograms, Figure 2C, no sign of melting attributable to the drug is 
seen, which indicates that the drug does not exist in crystalline form. The only 
prominent feature of the DSC thermograms, is a broad endotherm in the region of 40 - 
150 °C for BEA, but extends up to 250 °C for the loaded NaX-FAU.  
The spatial distribution of 5-FU on zeolitic particles was probed by means of XPS via 
its F and N atoms.  
The wide  spectra of NaX-FAU empty and NaX-FAU loaded samples which show 
that In, O , C , Al, Si , Na are present on the surface are depicted in Figure 3A. Small 
peaks of N1s and F1s are also present giving evidence for the presence of the drug in 
the zeolites. The wide scan spectra of BEA empty and BEA loaded samples, which 
show In, O, C and Si are illustrated in Figure 3B. The F1s and N1s peaks can be also 
traced for the loaded sample, but their presence is more apparent in the high 
resolution scans. 
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The atomic ratio for the 5-FU is found to be 0.47, in excellent agreement with the 
nominal value which is 0.50. For the NAX-FAU loaded sample only the area of the 
F1s peak that corresponds to the drug, at binding energy 688.5eV, was taken into 
account (Figure 3A) and from this the F:N surface atomic ratio was found to be 0.56. 
For the loaded BEA F:N=0.39. These values are tabulated in Table 1 together with the 
surface atomic ratios N:Si and F:Si for the empty and loaded samples.  
Overall the physicochemical characterization of the loaded zeolitic particles give 
evidence of the presence of 5-FU in both NaX-FAU and BEA zeolites. Bearing in 
mind that XPS is a surface sensitive spectroscopy obtaining about 40% of its signal 
from the first 2 or 3 nm, the small intensity of the F1s and N1s peaks for the loaded 
BEA sample could imply that 5-FU is located mainly in the pore structure of BEA 
zeolites. The higher intensity of these peaks for the loaded NAX-FAU indicates a 
more homogenous distribution of 5-FU in the zeolite’s channels and possible presence 
on its outer surface as well. (The XPS spectra of pure 5-FU and the N1s XPS peaks 
and F1s XPS peaks are available in SI, Figures S1A, S1B, S1C and S1D respectively). 
Encapsulation efficiency, release studies and molecular dynamics 
 The drug loading studies revealed significantly higher encapsulation efficiency for 
the NaX-FAU zeolite 16.18 ± 1.18 % (w/w) compared to BEA zeolite 6.02 ± 0.66 % 
(w/w) respectively. The higher amount to the NaX-FAU zeolite could be attributed 
higher loadings in the pore due to differences in pore size or geometry and possibly to 
the stronger interactions of the 5-FU with the pore walls of NaX-FAU particles 
compared to BEA particles.  
The release profiles of 5-FU from NaX-FAU and BEA particles are shown in Figure 
4A. The results show marked differences in the release profiles observed for the two 
zeolites used. A steep release of the drug from NaX-FAU particles was noticed. After 
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3 min ca. 83% of the initial amount the drug was released. Release from NaX-FAU 
shows exponential-type behaviour and is relatively rapid with the drug fully released 
within approximately 10 minutes.  There is no evidence from the release profile to 
suggest that diffusion from within the internal channel system of the framework is any 
different to that from the surface.   
On the contrary, in the case of BEA the release of 5-FU shows a multi-step profile, 
with about 15% of the drug being released in a distinct exponential step in the first 10 
minutes, another 40% being released in a subsequent step in 40 minutes, while the 
remaining amount is released within an hour. The overall release of the drug is much 
slower, and takes about twelve times longer to complete than for NaX-FAU.  
The effect of the acidic environment of the medium on the zeolite showed that the 
later is presumably the dominant factor rather than the medium for the release of the 
active compound. (SI Figures S2 and S3). 
The dissolution data were fitted to zero-order, first-order, Korsmeyer-Peppas, 
Higuchi, Hixson - Crowell and Weibull models. Dissolution models were fitted using 
the DDSolver add-in program for Microsoft Excel.
14
 
The determination coefficient (r
2
) was used to indicate the best fit model. The release 
rate constants were calculated from the slope of the various plots (Table S2).  
The in vitro drug release from zeolites was best explained by Weibull model, as the 
plots showed the highest linearity (r
2
 = 0.988) for NaX-FAU and (r
2
 = 0.997) for BEA 
zeolites respectively. Weibull plots can describe the dissolution curve in terms of 
applicable parameters. The shape parameter, β, characterizes the curve as either 
exponential (β=1), s-shaped with upward curvature followed by a turning point (β>1), 
or with a steeper initial slope than is consistent with the exponential (β<1). In the case 
of NaX-FAU zeolites the β parameter was 0.292 consistent with a steep release of 5-
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FU as evident from the release profile in Figure 4A.  In the case of BEA zeolite the β 
parameter was > 1 (2.415) exhibiting an s-shaped curvature as illustrated in Figure 
4A.  
The NaX-FAU particles are significantly larger so their external (geometrical) surface 
area is smaller than that of BEA. The micropore pore volumes and surface areas are 
similar; therefore it could be assumed that in the case of NaX-FAU the existence of 
the ~1.3 nm super cages or higher Al content allow the encapsulation of larger 
amounts of 5-FU. It is also anticipated that loading depends on the number of Na sites 
per unit cell (assuming that the interaction with the cation is one of the main reason 
that can cause adsorption). In that case the Si/Al ratio of BEA is ~250 which 
corresponds to 1 cation every ~4 unit cells. On the other hand NaX-FAU usually has 
Si/Al <1.5 meaning that numerous Na are available per unit cell. To make a 
quantitative comparison we need to make some normalization. However since each 
zeolite has a different number of Si, Al atoms in the unit cell, but considering the vast 
differences in Si/Al ratio a qualitative argument seems justified. In addition the nature 
of the zeolites might affect the release of the drug. For instance NaX-FAU is very 
hydrophilic so 5-FU might be released quickly because water molecules can be 
accommodated in the pores as well. On the contrary low Al content BEA is more 
hydrophobic repelling water molecules from the pores. The results showed that the 
release of 5-FU from NaX-FAU particles is rapid and that any molecules located 
inside the internal channel system are not released significantly slower than those on 
the surface.  However, release of 5-FU from BEA particles is prolonged by those 
molecules absorbed inside the BEA channel system.  In a recent study the release of 
5-FU from zeolites with different Si/Al ratios was studied in physiological medium.
15
 
12 
 
The results shown that the aluminum content was critical as the release of the drug 
was higher when the Si/Al ratio was increased. 
The molecular dynamics calculations support this interpretation of the experimental 
data. The molecular dynamics studies revealed that 5-FU displays significantly 
different diffusion rates for 5-FU molecules located inside the internal pore system of 
the two zeolites. The plots of root mean square (RMS) displacement against time are 
shown in Figure 4B.  In both cases, an upward slope is observed which shows that the 
drug is able to move through both zeolite frameworks at the temperature of the 
simulations (310 K).  The gradient obtained for NaX-FAU is significantly steeper 
than the one observed for BEA.  On this basis, it would be anticipated that the drug 
molecule would diffuse in and out of the NaX-FAU structure much more easily than 
through BEA.  This also implies that the drug should load inside the NaX-FAU 
structure more readily. Both of these predictions are consistent with the experimental 
observations. The dimensions of the largest pores in BEA, along the <100> direction, 
are approximately 6.6 x 6.7 Å whereas the windows between the cages along the 
<111> direction in NaX-FAU are slightly larger at 7.4 x 7.4 Å. The average non-
bonded interaction between the drug and the zeolite framework was -25.0 kcal mol
-1
 
in the BEA  structure but significantly less, -16.0 kcal mol
-1 
in NaX-FAU.  This 
difference is dominated by the increased van der Waals’ interaction between 5-FU 
and the BEA structure where the interaction is -23.3 kcal mol
-1 
compared with -15.7 
kcal mol
-1
 in NaX-FAU.  Electrostatic interactions between both frameworks and the 
drug have a much smaller difference, -0.3 kcal mol
-1 
for NaX-FAU and -1.7 kcal mol
-1 
for BEA and so we can attribute the difference in the diffusion rates to the ‘tighter fit’ 
of the 5-FU molecule in the BEA channel system which gives rise to much stronger 
short-range van der Waals interactions.  The molecular dynamic simulations show 
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that the increased interaction between 5-FU and BEA is not strong enough to prevent 
the molecule from diffusing along the zeolite’s channel, but that it is enough to exert a 
significant degree of controlled release. In contrast, movement of the drug through the 
NaX-FAU framework is much less hindered by the interaction between the internal 
walls of the zeolite structure and the molecule is able to diffuse in and out of NaX-
FAU much faster. The faster diffusion of 5-FU through NaX-FAU can also been seen 
in Figure 4D.  In NaX-FAU, the drug molecule moves rapidly within the cages of the 
structure before moving to the next cage via one of the interconnecting 
windows.  Residence time in the NaX-FAU cages is relatively small and several hops 
are made from cage to cage per 1000 ps, making diffusion relatively fast (Figure 
4D).  In contrast, over the same time period, 5-FU diffuses relatively slowly through 
the pore channel system of BEA, where the movement is much more constrained by 
the close 'fit' of the molecule inside the internal channels, (Figure 4C). 
Proliferative activity studies at Caco-2 cell monolayers  
Cytotoxicity studies for zeolites are rather scarce.
6,7,16, 
Cultured human intestinal 
epithelium is regarded a useful model for the study of oral drug absorption in that it 
allows a preliminary assessment of the permeability, toxicity, metabolism and 
transport of potential therapeutic agents.
17 
Cell growth, (expressed as cells/cm
2
 versus time), for the empty zeolite particles 
exhibited similar pattern to control-untreated Caco-2 cell cultures (Figure 5A & B). 
At 3 h no significant difference was noticed between the control and the free drug, 
empty zeolites and drug loaded samples either for BEA or NaX-FAU respectively 
(ANOVA , p>0.05).  
In the absence of drug, alterations in cell growth were noticed after 8 hr incubation 
with particles. Empty BEA particles at all concentrations tested showed no toxicity 
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compared to the control (ANOVA, p>0.05). On the contrary free drug and 5-FU 
loaded particles showed higher toxicity compared to the control (ANOVA, p<0.05). 
In the case of NaX-FAU particles, all the other formulations were significantly 
different compared to control (ANOVA, p<0.05) with the exception of empty NaX-
FAU particles at low concentrations (0.01 mg/mL).  
The cell growth significantly decreased (ANOVA, p<0.05) for all NaX-FAU 
formulations compared to the control at 24 h. However, when BEA formulations were 
tested the reduction of cell growth as compared to the control was minimal (ANOVA, 
p>0.05) for 0.1 and 0.01 mg/mL of empty zeolites respectively. After further 
incubation up to 48 hr in culture, the cells exhibited a small delay in reaching the 
plateau phase of cell growth. This effect on Caco-2 cell proliferation capacity has also 
been verified by calculating the half maximal inhibitory concentration [IC50] values 
for 24 and/or 48 h, respectively (Table S3, SI).   
There was no direct relation between the textural properties (e.g. BET values) of the 
zeolitic particles and cell viability. However the morphology of the particles might 
play a role in the cell growth. The multi-faceted NaX-FAU microparticles might 
penetrate cell membranes more easily compared with the almost spherical BEA 
nanoparticles. Finally, the size of the particles seems to affect the cell growth as the 
bigger NaX-FAU microparticles can induce higher toxicity to the cells compared to 
BEA nanoparticles. Previously toxicity studies of silicalite-1 nanoparticles with 
different crystal size (from 30 up to 500 nm) and surface functionalisation to human 
embryonic kidney 293 (HEK-293) cells and RAW264.7 macrophage cell lines 
showed that cell toxicity is type dependent.
17 
Template-free zeolites loaded with 
mitoxantrone tested in prostate cancer cells (PC-3) and mammary carcinoma cells 
(MCF-7) respectively. Empty zeolites showed no toxicity to both cell lines up to 0.5 
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mg/mL. When the drug was loaded, higher toxicity was exhibited compared with the 
empty ones. However lower toxicity values were obtained for drug loaded zeolites 
compared with the free drug.  
When 5-FU was loaded into zeolite particles, similar toxicity values were obtained as 
compared with that of free 5-FU (Figure 5 A & B). Importantly, in both cases, the 
loaded particles seem to alter the cell growth behavior in a dose-dependent manner. 
Moreover, the same trend was observed for drug-loaded particles and the 5-FU alone 
as evident from data shown in Figure 4 A & B.  
In broad agreement with previous studies,
18 
the IC50 values of 5-FU were estimated to 
0.0252 mg/mL (24 h) and 0.0239 mg/mL (48 h), respectively. The IC50 values for 
empty zeolites were significantly higher (t-test p<0.05) compared to free drug for both 
24 and 48 h (Table 2). On the contrary, drug-loaded zeolites being pharmacological 
active exhibited significantly lower (t-test p<0.05) IC50 values compared with the 
empty ones. It has to be noted that significantly lower IC50 values were calculated for 
drug-loaded NaX-FAU particles compared to BEA-loaded particles (t-test p<0.05) 
(Table 2). The latter difference might be explained from the release profiles of the 
drug where a fast release of 5-FU was observed from NaX-FAU zeolite (Figure 5A) 
allowing a more timely higher concentration of the drug to exhibit its cytotoxic 
activity faster compared to BEA-loaded particles.  
Effect of zeolitic particles on TEER values of Caco-2 cells 
Tight junctions serve as barriers to paracellular diffusion and the measurement of the 
transepithelial resistance (TEER) is believed to be a good indication of the tightness 
of the junctions between epithelial cells.
10
 Incubation of intestinal epithelial cells 
(Caco-2) with different BEA and NaX-FAU particles in concentrations of 0.01, 0,1 
and 1 mg/mL resulted in an immediate reduction of TEER values at 3 h up to 20% for 
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all concentrations (Figure 6 A and B). The highest reduction in TEER values was 
measured at a concentration of 1 mg/mL of BEA and NaX-FAU particles at 24 h thus 
the reduction in TEER is concentration-dependent. 
This reduction was statistically different from that shown with 0.01 mg/mL for all 
time points for the NaX-FAU particles (t-test p<0.05). In the case of BEA particles it 
was significantly different at 3, 8 and 24 h there was respectively. With removal of 
the zeolitic particles (indicated by an arrow at both graphs of Figure 6 (A & B) and 
substitution of the apical medium with fresh medium) reversibility of the effects was 
noticed. The monolayers started to recover slowly and a constant increase in 
resistance, toward the initial values was found. A comparison of the effect of the size 
of the particles on the TEER across Caco-2 cell monolayers revealed that the NaX-
FAU particles which are bigger have the tendency to induce a higher decrease to the 
TEER values (not significantly, t-test p>0.05). This final increase might be due to a 
reorganisation of junctional-complexes after they have been damaged by the exposure 
to zeolitic particles. From TEER recovery data obtained 24 h post-removal of the 
particles, it can be hypothesized that zeolites are not likely to affect cell viability. The 
TEER values are in accordance with the low toxicity of the zeolitic particles as 
evident from the MTT assay. The reduction of TEER values in the presence of 
zeolitic particles suggest their propensity to increase possible the paracellular 
permeability of active compounds. 
Discussion 
The two zeolite structures investigated in this study have different pore architectures 
and exhibit markedly different release profiles for the same drug.  Careful selection of 
the appropriate drug/framework combination is therefore crucial in determining the 
optimum system for drug delivery. The molecular dynamics method suggests that the 
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slower release rate observed for BEA can be attributed to the increased van der 
Waals’ interaction between the drug and the host framework.  This increased 
interaction is not large enough to prevent diffusion of the drug, but is sufficient to 
exert a considerable degree of controlled release. The agreement between the 
simulations and the observed release profiles suggests that molecular dynamics is a 
highly promising tool for screening zeolite/drug combinations prior to experimental 
investigation. Finally, cytocompatibility studies show that zeolitic particles are non-
toxic to human cells in vitro underlining their significant potential for in vivo 
applications. 
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FIGURE LEGENDS 
 
Figure 1 : The SEM images of the zeolite particles. (Insets) histograms representing 
statistical size distribution of the zeolite particles were generated from SEM image 
analysis for (A) BEA and (B) NaX-FAU particles. The N2 physisorption isotherms of 
(C) BEA and (D) NaX-FAU particles. 
 
Figure 2: (A) x-ray diffraction patterns of pure NaX-FAU and BEA zeolites and their 
complexes (B) FT-IR spectra of pure NaX-FAU and BEA zeolites and their 
complexes. (C) DSC thermograms of pure NaX-FAU and BEA zeolites and their 
complexes. 
 
Figure 3: X-ray photoelectron spectroscopy (XPS) spectra of (A) of NAX-FAU 
empty and NAX-FAU loaded surfaces and (B) BEA empty and BEA loaded surfaces 
 
Figure 4: (A) Release profiles of 5-FU from BEA and NaX-FAU particles in 
simulated gastric fluid. The error bars indicated are mean ± S.D. (n = 3). (B) Root-
mean displacement graphs for 5-FU inside the zeolite beta (BEA) framework and 
faujisite (NaX-FAU). Diffusion of 5-FU through the channel system of (C) BEA and 
(D) NaX-FAU.  The location of the drug molecule is shown every 10 ps during the 
first 1000 ps of the simulations. 
 
Figure 5: Caco-2 cell viability at 3, 8 24 and 48 h after incubation with (A) BEA and 
(B) NaX-FAU zeolitic particles empty and loaded with 5-FU.  The data are given as 
mean ± S.D. (n=3). 
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Figure 6 : Application of zeolite particles at increasing concentrations (% w/v) on 
Caco-2 cell intestinal epithelia at pH 7.4 and their effect on the TEER, (n=3) (A) 
BEA, (B) NaX-FU particles respectively. (The arrows indicate that samples removed 
and cells washed at 24 h). 
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FIGURE 4 
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FIGURE 6 
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Table 1: Surface atomic ratios for 5-FU and for the empty and loaded zeolites.  
Sample N/Si F/Si F/N 
5-fluorouracil - - 0.47 
BEA empty 0
 
0 - 
BEA loaded 0.023 0.009 0.39 
NaX-FAU empty 0 0* - 
NaX-FAU loaded 0.132 0.070 0.56 
*below detection limit 
 
 
 
